Prajjwal P, Sanga HSF, Acharya K, Tango T, John J, Rodriguez RS, Marsool MDM, Sulaimanov M, Ahmed A, Hussin OA (2023) Parkinson’s disease updates: Addressing the pathophysiology, risk factors, genetics, diagnosis, along with the medical and surgical treatment. Annal Med Surg 85(10):4887–4902

Article  Google Scholar 

Bhusal CK, Uti DE, Mukherjee D, Alqahtani T, Alqahtani S, Bhattacharya A, Akash S (2023) Unveiling Nature’s potential: promising natural compounds in Parkinson’s disease management. Parkinsonism Related Disorders 115:105799

Article  CAS  PubMed  Google Scholar 

Landau R, Halperin R, Sullivan P, Zibly Z, Leibowitz A, Goldstein DS, Sharabi Y (2022) The rat rotenone model reproduces the abnormal pattern of central catecholamine metabolism found in Parkinson’s disease. Dis Model Mech 15(1):049082

Article  Google Scholar 

Hunt J, Coulson EJ, Rajnarayanan R, Oster H, Videnovic A, Rawashdeh O (2022) Sleep and circadian rhythms in Parkinson’s disease and preclinical models. Mol Neurodegener 17:1–21

Article  Google Scholar 

Rathor P, Ch R (2023) Metabolic basis of circadian dysfunction in Parkinson’s disease. Biology 12(10):1294

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Lv D, Liu W, Li S, Chen J, Shen Y, Wang F, Hu LF, Liu CF (2018) Disruption of the circadian clock alters antioxidative defense via the SIRT1-BMAL1 pathway in 6-OHDA-induced models of Parkinson’s disease. Oxidat Med Cellular Longevity 2018(1):4854732

Article  Google Scholar 

McKee CA (2023) Circadian protein BMAL1 regulates astrocyte activation and protein degradation in health and disease. Washington University in St. Louis

Google Scholar 

Moujalled D, Strasser A, Liddell JR (2021) Molecular mechanisms of cell death in neurological diseases. Cell Death Differ 28(7):2029–2044

Article  PubMed  PubMed Central  Google Scholar 

Ding XS, Gao L, Han Z, Eleuteri S, Shi W, Shen Y, Song ZY, Su M, Yang Q, Qu Y, Simon DK (2023) Ferroptosis in Parkinson’s disease: molecular mechanisms and therapeutic potential. Ageing Res Rev 91:102077

Article  CAS  PubMed  Google Scholar 

Liu N, Lin X, Huang C (2020) Activation of the reverse trans-sulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance. Br J Cancer 122:279–292

Article  CAS  PubMed  Google Scholar 

Suh JH, Shenvi SV, Dixon BM, Liu H, Jaiswal AK, Liu RM, Hagen TM (2004) Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci U S A 101(10):3381–3386

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koentjoro B, Park JS, Sue CM (2017) Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson’s disease. Sci Rep 7(1):44373

Article  PubMed  PubMed Central  Google Scholar 

Ganley IG (2022) Strengthening the link between mitophagy and Parkinson’s disease. Brain 145(12):4154–4156

Article  PubMed  PubMed Central  Google Scholar 

Cheng Y, Feng S, Sheng C, Yang C, Li Y (2024) NOB from citrus peel: a promising therapeutic agent for liver disease-pharmacological characteristics, mechanisms, and potential applications. Front Pharmacol 15:1354809

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fang H, Zhang L, Zhao H (2023) Potential role of NOB in Alzheimer’s disease. J Food Bioact. https://doi.org/10.31665/JFB.2023.18361

Article  Google Scholar 

Yabuki Y, Ohizumi Y, Yokosuka A, Mimaki Y, Fukunaga K (2014) Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice. Neuroscience 259:126–141

Article  CAS  PubMed  Google Scholar 

Salem EA, Alqahtani SM, El-Shoura EA, Zaghlool SS, Abdelzaher LA, Mohamed SA, Alalhareth IS, Sheref AA (2025) Neuroprotective effects of semaglutide and metformin against rotenone-induced neurobehavioral changes in male diabetic rats. Naunyn-Schmiedeberg’s Arch Pharmacol. https://doi.org/10.1007/s00210-025-03920-7

Article  Google Scholar 

Zaitone SA, Ahmed E, Elsherbiny NM, Mehanna ET, El-Kherbetawy MK, ElSayed MH et al (2019) Caffeic acid improves locomotor activity and lessens inflammatory burden in a rat model of rotenone-induced nigral neurodegeneration: relevance to Parkinson’s disease therapy. Pharmacol Rep 71:32–41. https://doi.org/10.1016/j.pharep.2018.08.004

Article  CAS  PubMed  Google Scholar 

Belviranlı M, Okudan N, Sezer T (2025) Potential therapeutic effects of curcumin, with or without L-DOPA, on motor and cognitive functions and hippocampal changes in rotenone-treated rats. Metab Brain Dis 40(4):174

Article  PubMed  PubMed Central  Google Scholar 

Ahiskalioglu EO, Aydin P, Ahiskalioglu A, Suleyman B, Kuyrukluyildiz U, Kurt N, Altuner D, Coskun R (2018) The effects of ketamine and thiopental used alone or in combination on the brain, heart, and bronchial tissues of rats. Arch Med Sci 14(3):645. https://doi.org/10.5114/AOMS.2016.59508

Article  CAS  PubMed  Google Scholar 

Lowry D (1951) Protein measurements with the Folin phenol reagent. J Biol Chem 193:265–275

Article  CAS  PubMed  Google Scholar 

Ellman GL, Courtney DK, Andreas V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95

Article  CAS  PubMed  Google Scholar 

Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25(4):402–408

Article  CAS  PubMed  Google Scholar 

Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358

Article  CAS  PubMed  Google Scholar 

Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169

CAS  PubMed  Google Scholar 

Beutler E, Duron O, Kelly BM (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 61:882–888

CAS  PubMed  Google Scholar 

Tenhunen R, Marver HS, Schmid R (1968) The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci 61(2):748–755

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baik D et al (2022) Prevalence and patterns of the concurrent use of anticholinergics for the motor symptoms of Parkinson’s disease and acetylcholinesterase inhibitors in Parkinson’s disease patients with dementia: a cross-sectional study using Korea National Health Insurance claims data. BMC Geriatr 22(1):609

Article  CAS  PubMed  PubMed Central  Google Scholar 

Walczak-Nowicka ŁJ, Herbet M (2021) Acetylcholinesterase inhibitors in the treatment of neurodegenerative diseases and the role of acetylcholinesterase in their pathogenesis. Int J Mol Sci 22(17):9290

Article  CAS  PubMed  PubMed Central  Google Scholar 

El-Sherbeeny NA et al (2020) The protective effect of biochanin A against rotenone-induced neurotoxicity in mice involves enhancing of PI3K/Akt/mTOR signaling and beclin-1 production. Ecotoxicol Environ Saf 205:111344

Article  CAS  PubMed  Google Scholar 

Altharawi A et al (2022) Europinidin Inhibits rotenone-activated parkinson’s disease in rodents by decreasing lipid peroxidation and inflammatory cytokines pathways. Molecules 27(21):7159

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jung UJ, Kim SR (2018) Beneficial effects of flavonoids against Parkinson’s disease. J Med Food 21(5):421–432

Article